艾
IQV
艾昆緯
157.77
-0.60-0.38%After Hours: 158.40 +0.63 +0.40%19:59 05/01 EDT
OPEN/PREV CLOSE158.50/157.77
TODAY RANGE158.00-161.40
VOL300
MARKET CAP27.02B
52 WEEK RANGE134.65-247.05
AVG VOL (3M)2.07M
% TURNOVER1.86%
TURNOVER91.73M
P/E (TTM)20.53
% RANGE2.16%
EPS(TTM)7.84
P/E(FORWARD)20.01
P/B4.197
BVPS38.34
DIVIDEND--
P/S1.674
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP26.72B
SHARES OUTSTANDING167.87M
NEXT EARNINGS05/04-05/08
FREE FLOAT166.02M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·11h ago
Here are the major earnings before the open Tuesday
The Motley Fool·20h ago
Veeva Systems Just Joined the S&P 500. 3 Reasons to Buy It and 1 Not To.
Simply Wall St·2d ago
A Look At IQVIA Holdings' (IQV) Valuation After Its US$3.14b ESOP Shelf Registration Filing
Seeking Alpha·4d ago
Lilly CEO says Foundayo launch will be "just fine"
Simply Wall St·6d ago
Is It Time To Revisit IQVIA (IQV) After Its Sharp Year To Date Share Price Drop
Barchart·04/27 06:30
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
Barron‘s·04/24 15:46
Eli Lilly Stock Falls. Foundayo Is Fighting to Catch Novo's Wegovy Pill.
Seeking Alpha·04/24 12:10
Eli Lilly slips as obesity scripts said to trail those for Novo’s Wegovy
TipRanks·04/23 21:18
IQVIA Shareholders Approve New 2026 Incentive Plan
Dow Jones·04/23 20:34
IQVIA Holdings Inc. Stock Sheds 8.3%, Underperforms Peers
MarketWatch·04/23 20:30
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors
Seeking Alpha·04/17 11:25
Lilly weight loss pill prescriptions said to near 1,400 in first week of launch
Seeking Alpha·04/17 10:27
OpenAI launches GPT-Rosalind, an AI model for life sciences research
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.